Beauty Farm Medical and Health Industry Inc. disclosed that on 29 October 2026 it repurchased 13,000 ordinary shares on the Hong Kong Stock Exchange, paying between HKD 16.18 and HKD 16.41 per share. The volume-weighted average purchase price was HKD 16.2612, bringing the total cash outlay to HKD 0.21 million.
Following the transaction, Beauty Farm’s issued share capital (excluding treasury shares) fell by 0.0053% to 247.45 million shares, while treasury shares increased to 4.14 million. The company’s total issued share count remained unchanged at 251.59 million shares.
The buyback forms part of the mandate approved on 26 June 2026, which authorises the repurchase of up to 24.85 million shares. Including the latest transaction, Beauty Farm has repurchased 1.07 million shares under this mandate, equivalent to 0.43% of the shares outstanding on the mandate date. In line with Hong Kong listing rules, the company is restricted from issuing new shares or selling treasury shares until 28 November 2026.
Comments